Clinical immunology<BR>Periodontal disease and cytokine inhibitors

Sylwia Małgorzata Słotwińska; Robert Słotwiński

eISSN: 1644-4124
ISSN: 1426-3912

Central European Journal of Immunology

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

1-2/2006
vol. 31

Send email

Copy url:

abstract:

Clinical immunology
Periodontal disease and cytokine inhibitors

Sylwia Małgorzata Słotwińska

,

Robert Słotwiński

(Centr Eur J Immunol 2006; 31 (1-2): 22-24)

Online publish date: 2006/10/12

View full text Get citation

The aim of the presented paper was to examine the occurrence in saliva of interleukin – 1 receptor antagonist (IL-1 ra) and soluble receptor type I of tumor necrosis factor (sTNF RI) in patients with periodontitis. The levels of interleukin-1 receptor antagonist and soluble TNF receptor type I (s TNF RI, p55) in saliva were determined with an immunoenzymatic ELISA method using a factory-ready quantitative enzymatic test manufactured by Quantikine, R&D System. The level of occurrence for interleukin-1 receptor antagonist (IL-1 ra) in saliva was statistically significantly higher (p<0.05) in persons with periodontitis as compared with the control group.

keywords:

Clinical immunologyPeriodontal disease and cytokine inhibitors

Sylwia Małgorzata Słotwińska , Robert Słotwiński

periodontal disease, interleukin – 1 receptor antagonist (IL-1 ra), soluble receptor type I of tumor necrosis factor (sTNF RI)

Clinical immunology
Periodontal disease and cytokine inhibitors

Sylwia Małgorzata Słotwińska

,

Robert Słotwiński